Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
AvalonBay Communities
AVB
$26.6B
| $2.48M | ﹤0.01% |
14,727
-6,505
| -31% | -$1.11M |
|
|
WCN
452
Waste Connections
WCN
$42.2B
| $2.45M | ﹤0.01% |
17,590
-15,752
| -47% | -$2.1M |
|
453
iShares MSCI ACWI ETF
ACWI
$33.3B
| $2.44M | ﹤0.01% |
26,773
-80,513
| -75% | -$7.18M |
|
454
Prothena Corp
PRTA
$449M
| $2.39M | ﹤0.01% |
49,233
-8
| -0% | -$423 |
|
455
Keysight
KEYS
$57.6B
| $2.36M | ﹤0.01% |
14,600
+939
| +7% | +$159K |
|
456
State Street Energy Select Sector SPDR ETF
XLE
$38.1B
| $2.21M | ﹤0.01% |
53,306
+1,098
| +2% | +$46.9K |
|
457
Synopsys
SNPS
$77.7B
| $2.1M | ﹤0.01% |
5,446
+4,782
| +720% | +$1.71M |
|
458
New Jersey Resources
NJR
$5.53B
| $1.98M | ﹤0.01% |
37,308
+10,160
| +37% | +$518K |
|
459
Coca-Cola
KO
$374B
| $1.84M | ﹤0.01% |
29,720
-1,966
| -6% | -$119K |
|
460
Iridium Communications
IRDM
$5.12B
| $1.81M | ﹤0.01% |
29,209
-1,389
| -5% | -$83.1K |
|
461
Sanmina
SANM
$11B
| $1.68M | ﹤0.01% |
27,603
-1,051
| -4% | -$63K |
|
462
CNO Financial Group
CNO
$5.14B
| $1.58M | ﹤0.01% |
71,076
-10,490
| -13% | -$251K |
|
|
LTC
463
LTC Properties
LTC
$2.02B
| $1.51M | ﹤0.01% |
43,119
+14,175
| +49% | +$510K |
|
464
Vanguard Morningstar Growth ETF
VUG
$229B
| $1.5M | ﹤0.01% |
36,198
-86,574
| -71% | -$3.37M |
|
|
PCH
465
DELISTED
PotlatchDeltic
PCH
| $1.49M | ﹤0.01% |
30,188
-1,589
| -5% | -$74.6K |
|
466
Black Hills Corp
BKH
$5.54B
| $1.48M | ﹤0.01% |
23,434
-1,575
| -6% | -$104K |
|
|
TPH
467
DELISTED
Tri Pointe Homes
TPH
| $1.47M | ﹤0.01% |
57,962
+8,040
| +16% | +$182K |
|
468
Evertec
EVTC
$1.85B
| $1.45M | ﹤0.01% |
43,067
+15,113
| +54% | +$531K |
|
469
Ares Management
ARES
$31.2B
| $1.41M | ﹤0.01% |
16,948
-4,669
| -22% | -$371K |
|
470
Ascendis Pharma A/S
ASND
$16.4B
| $1.4M | ﹤0.01% |
13,080
-580
| -4% | -$66.4K |
|
471
UFP Industries
UFPI
$5.19B
| $1.38M | ﹤0.01% |
17,322
-6,358
| -27% | -$544K |
|
472
NMI Holdings
NMIH
$3.31B
| $1.36M | ﹤0.01% |
60,911
+23,306
| +62% | +$523K |
|
473
Adaptive Biotechnologies
ADPT
$3.75B
| $1.35M | ﹤0.01% |
152,414
-42,622
| -22% | -$376K |
|
|
DENN
474
DELISTED
Denny's
DENN
| $1.3M | ﹤0.01% |
116,877
-16,819
| -13% | -$196K |
|
|
PDM
475
Piedmont Realty Trust
PDM
$1.18B
| $1.29M | ﹤0.01% |
+176,283
| New | +$1.62M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.